Stocks Health care ZBH
NYSE · Health careZimmer Biomet Holdings, Inc. (ZBH)
Zimmer Biomet Holdings, Inc. brought in $8.5B of revenue over the twelve months to June 30, 2026, up 8.6% from a year earlier. Net income was $806.7M, a net margin of 9.5%. Operating cash flow minus capital spending left $1.5B of free cash flow in fiscal 2025. At June 30, 2026 it held $410M in cash against $7.5B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about Zimmer Biomet Holdings, Inc.
- Net worth
- Zimmer Biomet Holdings, Inc. has a market value (market cap) of $17.4B at the latest share price, and shareholders' equity of $12.6B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $8.2B (+7.2% year on year), with net income of $705.1M. Over the 12 months to June 30, 2026: revenue $8.5B, net income $806.7M.
- Cash flow
- In fiscal 2025 operations brought in $1.7B of cash; after $224.5M of capital spending, free cash flow was $1.5B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Zimmer Biomet Holdings, Inc.'s next report is expected around November 4, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- Zimmer Biomet Holdings, Inc. declared dividends of $0.96 per share in fiscal 2025, a yield of 1.05% at the current price.
What Zimmer Biomet Holdings, Inc. does
Zimmer Biomet Holdings designs and manufactures orthopedic implants, surgical equipment, and digital health tools. Its products include artificial knee, hip, shoulder, and dental replacements. These are purchased primarily by hospitals, surgeons, and healthcare providers for reconstructive surgery and musculoskeletal treatment. Its shares trade on NYSE under the ticker ZBH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $8.2B | $705.1M | $3.55 | $1.5B |
| 2024 | $7.7B | $903.8M | $4.43 | $1.3B |
| 2023 | $7.4B | $1B | $4.88 | $1.3B |
| 2022 | $6.9B | $231.4M | $1.10 | $1.2B |
| 2021 | $6.8B | $401.6M | $1.91 | $1.4B |
| 2020 | $6.1B | -$138.9M | -$0.67 | $1.1B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ZBH ranks in Health care
Dividends
Zimmer Biomet Holdings, Inc. declared $0.96 per share in fiscal 2025. At the current price that is a yield of 1.05%. It paid out $190.3M in cash dividends, 27% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | $0.96 | $190.3M | 27% |
| 2024 | $0.96 | $196M | 22% |
| 2023 | $0.96 | $200.9M | 20% |
| 2022 | $0.96 | $201.2M | 87% |
| 2021 | $0.96 | $200.1M | 50% |
| 2020 | $0.96 | $198.5M | n/a |
Latest SEC filings
What Zimmer Biomet Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake (5% or more) SCHEDULE 13G
- August 5, 2026Other event 8-K
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 4.8% to $2.2B versus the same quarter last year; diluted EPS $1.03 versus $0.77.
- August 5, 2026
- June 29, 2026
- May 27, 2026
- May 27, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
What is ZBH worth? A DCF from its reported cash flow
Insider trades
What the people running Zimmer Biomet Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $824K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 1, 2026 | Campbell Gary CraigPresident, Americas | Exercised options | 2,368 | - |
| October 1, 2026 | Campbell Gary CraigPresident, Americas | Shares withheld for tax | 932 | $82.4K |
| October 1, 2026 | Campbell Gary CraigPresident, Americas | Exercised options | 1,218 | - |
| October 1, 2026 | Campbell Gary CraigPresident, Americas | Shares withheld for tax | 480 | $42.4K |
| September 11, 2026 | Thornal Kevin RGrp Pres-Global Business | Sold | 5,691 | $529K |
| September 4, 2026 | Phipps Chad FSee remarks below. | Sold | 3,000 | $295.1K |
| August 1, 2026 | Thornal Kevin RGrp Pres-Global Business | Exercised options | 9,957 | - |
| August 1, 2026 | Thornal Kevin RGrp Pres-Global Business | Shares withheld for tax | 4,266 | $395.4K |
Who owns ZBH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Dodge & Cox13G, passive | 12.5% | August 13, 2026 |
| Vanguard Capital Management13G, passive | 7.54% | April 30, 2026 |
| Capital International Investors13G, passive | 6.4% | August 12, 2026 |
| Harris Associates L P13G, passive with 1 related filers | 6.2% | February 17, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 908 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Dodge & Cox | 24,124,735 | +582,035 |
| BlackRock, Inc. | 15,614,847 | +274,041 |
| Harris Associates L P | 12,738,025 | -221,914 |
| Vanguard Capital Management LLC | 12,634,937 | -158,475 |
| Capital International Investors | 12,183,614 | +3,064,392 |
| State Street Corp | 8,877,171 | +52,044 |
| Vanguard Portfolio Management LLC | 8,441,747 | -208,481 |
| Geode Capital Management, LLC | 5,349,223 | -30,302 |
| Invesco Ltd. | 3,979,860 | +374,435 |
| Primecap Management Co | 3,816,680 | -90,470 |
| Van Eck Associates Corp | 3,501,654 | -262,266 |
| Citadel Advisors LLC | 3,477,472 | +2,098,807 |
| Hotchkis & Wiley Capital Management LLC | 2,761,429 | -30,960 |
| UBS Group AG | 2,758,615 | +1,385,250 |
| American Century Companies Inc | 2,744,463 | -1,218,743 |
| Morgan Stanley | 2,591,503 | +561,688 |
| Bank of America Corp | 2,177,724 | +627,934 |
| Northern Trust Corp | 1,965,052 | -58,015 |
| Dimensional Fund Advisors LP | 1,958,313 | -265,850 |
| Equity Investment Corp | 1,681,360 | -62,944 |
Insiders
9 insiders reported holding 299,280 shares in total, about $27.3M at the last price.
| Holder | Shares |
|---|---|
| Tornos IvanChairman, President and CEO, Director | 83,191 |
| Upadhyay SuketuExec VP, CFO | 69,485 |
| Phipps Chad FSee remarks below. | 65,231 |
| Van Zuilen WilfredGroup Pres, EMEA | 30,991 |
| Yi SangGroup President, Asia Pacific | 27,251 |
| Winkler LoriSVP and CHRO | 10,224 |
| Stellato Paul AVP, Controller, CAO | 5,582 |
| Noor JehanzebSee remarks below. | 5,151 |
| Campbell Gary CraigPresident, Americas | 2,174 |
Questions about ZBH
What does Zimmer Biomet Holdings, Inc. do?
Zimmer Biomet Holdings designs and manufactures orthopedic implants, surgical equipment, and digital health tools. Its products include artificial knee, hip, shoulder, and dental replacements. These are purchased primarily by hospitals, surgeons, and healthcare providers for reconstructive surgery and musculoskeletal treatment. Its shares trade on NYSE under the ticker ZBH.
What is Zimmer Biomet Holdings, Inc.'s net worth?
Zimmer Biomet Holdings, Inc. has a market value (market cap) of $17.4B at the latest share price, and shareholders' equity of $12.6B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Zimmer Biomet Holdings, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $806.7M on revenue of $8.5B, a net margin of 9.5%.
How much revenue does Zimmer Biomet Holdings, Inc. make?
Over the twelve months to June 30, 2026 Zimmer Biomet Holdings, Inc. reported revenue of $8.5B. That is 8.6% more than a year earlier.
When did Zimmer Biomet Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 5, 2026.
When is Zimmer Biomet Holdings, Inc.'s next earnings report?
Zimmer Biomet Holdings, Inc.'s next report is expected around November 4, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Does Zimmer Biomet Holdings, Inc. pay a dividend?
Yes. Zimmer Biomet Holdings, Inc. declared dividends of $0.96 per share in fiscal 2025, a yield of 1.05% at the current price.
Theses that mention ZBH
Similar companies
Compare ZBH with
Follow ZBH
Get an email when Zimmer Biomet Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Zimmer Biomet Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.